Companies: 10,795·Total market cap: $144.5T
Magenta Therapeutics, Inc.

Magenta Therapeutics, Inc.

MGTANASDAQHealthcare
$0.70
$-0.06(-7.74%)
Market Cap$42441024
P/E Ratio
52W High$1.81
52W Low$0.321
Overview

Magenta Therapeutics, Inc.(MGTA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · MGTA · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122022-122021-122020-12
Revenue
Revenue$2.04M$6.24M$0.00M$0.00M$0.00M
Cost of Revenue$0.00M$0.00M$0.00M$0.00M$0.00M
Gross Profit$0.00M$0.00M$0.00M$0.00M$0.00M
Gross Margin %(computed)0.00%0.00%
Operating Expenses
R&D Expenses$145.64M$83.11M$55.14M$46.77M$50.62M
G&A Expenses$34.33M$24.99M$25.76M$27.93M$28.09M
Total Operating Expenses$179.97M$108.10M$80.90M$74.69M$78.70M
Operating Income($177.93M)($101.86M)($80.90M)($74.69M)($78.70M)
Operating Margin %(computed)
Interest Income$16.12M$17.36M$0.00M$3.56M$3.77M
Interest Expense$0.00M$0.00M($4.44M)$0.00M$0.00M
Income Before Tax($162.34M)($84.97M)($76.46M)($71.14M)($74.94M)
Income Tax Expense$0.00M$0.00M($4.44M)($5.58M)($5.74M)
Net Income($162.34M)($84.97M)($72.02M)($65.56M)($69.19M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$0.00$-21.75$-23.05$-1.12$-1.43
Wtd Avg Shares0.00M3.91M3.12M58.79M48.46M
EBITDA($177.93M)($101.86M)($78.98M)($74.69M)($78.70M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Magenta Therapeutics, Inc.

关于Magenta Therapeutics, Inc.(MGTA)损益表

Magenta Therapeutics, Inc.(MGTA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,MGTA实现营收$0.00B,毛利润$0.00B(毛利率0.00%),净利润($0.16B)(净利率-7973.33%)。

常见问题

MGTA · 4 问

Magenta Therapeutics, Inc.(MGTA)2025财年营收为$0.00B,同比down67.3%。

MGTA revenueMGTA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09